Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism
Public ClinicalTrials.gov record NCT03681808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism Soft Contact Lens When Worn on a Daily Basis
Study identification
- NCT ID
- NCT03681808
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 242 participants
Conditions and interventions
Conditions
Interventions
- Control Device
- Test Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2018
- Primary completion
- Dec 15, 2019
- Completion
- Dec 15, 2019
- Last update posted
- Jan 7, 2021
2018 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 117 | Irvine | California | 92618 | — |
| Bausch Site 107 | San Diego | California | 92123 | — |
| Bausch Site 101 | San Francisco | California | 94112 | — |
| Bausch Site 108 | San Jose | California | 95132 | — |
| Bausch Site 104 | Sunnyvale | California | 94087 | — |
| Bausch Site 102 | Jacksonville | Florida | 32250 | — |
| Bausch Site 116 | Bloomington | Illinois | 61701 | — |
| Bausch Site 110 | Brighton | New York | 14618 | — |
| Bausch Site 118 | New York | New York | 10022 | — |
| Bausch Site 111 | New York | New York | 10036 | — |
| Bausch Site 114 | Raleigh | North Carolina | 27603 | — |
| Bausch Site 105 | Houston | Texas | 77204 | — |
| Bausch Site 115 | Issaquah | Washington | 98027 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03681808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03681808 live on ClinicalTrials.gov.